Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to know ...

AI-powered drug company spun out of Google’s DeepMind says human trials are ‘very close’ After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials.

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.

Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in ...

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

A team from Google DeepMind and several universities introduces Aeneas, a generative (and free) AI model designed to help ...

Neuralink achieved two brain transplants in a day, targeting 20 by year-end. CEO Elon Musk envisions healing paralysis and ...

Microsoft has hired 24 former DeepMind employees, including Amar Subramanya as its new AI VP, in a major move to strengthen ...

Co-founded by Elon Musk in 2016, Neuralink’s ‘patient one,’ Noland Arbaugh, received the first Brain Chip Implant (BCI) in ...

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are also racing to use AI in drug discovery.

Below are the most-read DIGITIMES Asia stories from July 7 to July 13, 2025. This week's top three highlights include China’s ...